Hyperlipidemias and Atherosclerotic Cardiovascular Disease ________________________________________ Hyperlipidemias and Atherosclerotic Cardiovascular Disease MDAK10HA — 10 CREDIT HOURS R elease D ate : 08/01/25 E xpiration D ate : 07/31/28
7. Select an appropriate strategy for managing hyper- lipidemia, including diet, lifestyle modification, and pharmacologic treatment. 8. Discuss the targeting of specific steps in lipid syn- thesis and metabolism related to the mechanism of action of drugs that inhibit cholesterol absorp- tion in the intestine. 9. Describe the therapeutic efficacy and indications of fibrates, statins, and nicotinic acid derivatives. 10. Determine the role of fish oil derivatives and ste- rols and stanols in the management of hyperlipid- emias. 11. Identify patients at risk for coronary heart disease and outline the evidence-based guidelines for the treatment of these patients. Faculty A. José Lança, MD, PhD , received his Medical Degree at the University of Coimbra in Coimbra, Portugal, and completed his internship at the University Hospital, Coimbra. He received his PhD in Neurosciences from a joint program between the Faculties of Medicine of the University of Coimbra, Portugal, and the University of Toronto, Toronto, Canada. He was a Gulbenkian Foundation Scholar and was awarded a Young Investigator Award by the American National Association for the Research of Schizophrenia and Depression (NARSAD). (A complete biography appears at the end of this course.) Faculty Disclosure Contributing faculty, A. José Lança, MD, PhD, has disclosed no relevant financial relationship with any product manufac- turer or service provider mentioned. Division Planners John V. Jurica, MD, MPH Randall L. Allen, PharmD Mary Franks, MSN, APRN, FNP-C Senior Director of Development and Academic Affairs Sarah Campbell
HOW TO RECEIVE CREDIT
• Read the enclosed course. • Complete the final examination questions at the end. A score of 70% is required. • Return your customer information/answer sheet, evaluation, and payment to InforMed by mail or complete online at BOOK.CME.EDU.
Audience This course is designed for physicians, physician assistants, nurses, and pharmacy professionals who may intervene to limit the effects of hyperlipidemias in their patients, promoting better long-term health and preventing cardiovascular disease. Course Objective The purpose of this course is to provide a review of hyperlip- idemia in the pathogenesis of cardiovascular disease, as well as the therapeutic benefits of pharmacologic and nonphar- macologic approaches to treatment. The objectives are to promote team-based care, foster patient awareness and shared provider-patient decision-making, and promote implementa- tion of lifestyle changes and compliance with guideline-directed therapy for prevention of cardiovascular disease. Learning Objectives Upon completion of this course, you should be able to: 1. Discuss the incidence of cardiovascular disorders, expected epidemiologic trends, and relevance to society and healthcare systems. 2. Discuss the relevance of hyperlipidemias in the etiology of atherosclerosis and cardiovascular diseases. 3. Identify risk factors for hyperlipidemias. 4. Describe the exogenous and endogenous pathways of lipid synthesis and metabolism. 5. Describe the various types of lipoproteins. 6. Evaluate lipid profiles and identify the most clini- cally relevant types of hyperlipidemias.
23 Mention of commercial products does not indicate endorsement.
MDAK1526
Powered by FlippingBook